The Impact of De‐escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention

The Impact of De‐escalation of Antianginal Medications on Health Status After Percutaneous Coronary Intervention

BackgroundAntianginal medications (AAMs) can be perceived to be less important after percutaneous coronary intervention (PCI) and may be de‐escalated after revascularization. We examined the frequency of AAM de‐escalation at discharge post‐PCI and its association with follow‐up health status. Method...

Full description

Bibliographic Details
Main Authors: Mohammed Qintar, Arooge Towheed, Fengming Tang, Adam C. Salisbury, P. Michael Ho, J. Aaron Grantham, John A. Spertus, Suzanne V. Arnold
Format: Article
Language:English
Published: Wiley 2017-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
angina
anti‐anginal medications
de‐escalation
health status
health‐related quality of life
medical therapy
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.117.006405

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.117.006405

Similar Items